New WHO guideline on care and treatment of chronic hepatitis C

WHO published guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. For those who need more in-depth information on chronic hepatitis C treatment, this guideline can be useful. You can download from Resources under sub heading Guidelines or you can directly download from the link ……..Guidelines for the Care and Treatment of persons diagnosed with chronic hepatitis C virus infections

/ News

Share the Post

Related Posts

IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016